ClinicalTrials.Veeva

Menu

Interest of New MRI Sequences After Embolization of Brain Arteriovenous Malformations (MAV-IRM)

F

Fondation Ophtalmologique Adolphe de Rothschild

Status

Terminated

Conditions

Brain Arteriovenous Malformations

Study type

Observational

Funder types

NETWORK

Identifiers

NCT02896881
RBC_2016_7

Details and patient eligibility

About

In previous studies exploring specific sequences of MRI (susceptibility weighted imaging (SWI) and arterial spin labeling (ASL)), the investigators have shown the great sensibility of these MRI sequences to detect arteriovenous shunts, compared to angiography imaging (static or dynamic). This prospective study aims to compare multisequence MRI to brain arteriography imaging in patients undergoing brain arteriovenous malformations embolization.

Full description

Cerebral arteriovenous malformations are treated to eliminate the potential risk of haemorrhage. There are three possible treatment modalities: surgery, radiosurgery or embolisation. Complete exclusion of the arteriovenous malformation is a prerequisite for confirming that there is no residual risk of haemorrhage. After treatment, arteriography is the gold standard for confirming this exclusion. The absence of early opacification of the venous drainage is considered a sign of cure.

Several arteriographic aspects are possible after treatment by embolisation:

  • Arteriography may be strictly normal (no abnormalities).
  • The persistence of early venous opacification (presence of arterialised blood) indicates the persistence of a residual AVM.
  • Other vascular anomalies without early venous drainage may be present: dysplastic vessels (irregular shape, "corkscrew" appearance) ; capillary blush in the embolisation bed (hyperaemia) ; other: slow flow, slow filling, or widening of afferent arteries.

Our previous studies exploring the use of specific MRI sequences, in magnetic susceptibility (SWI), arterial spin labelling (ASL) and angiography (static or dynamic) sequences, have enabled us to demonstrate the very high sensitivity of these sequences for detecting an arteriovenous shunt, whether native (when the AVM is discovered) or residual after treatment. We would like to carry out a prospective study to compare cerebral arteriography and MRI (multi-sequence) in patients treated by embolisation for cerebral arteriovenous malformation.

Enrollment

53 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patient ≥ 18 years old
  • with brain Arteriovenous Malformations
  • embolization treatment scheduled

Exclusion criteria

  • patient's refusal to participate in the study
  • contraindication to undergo MRI examination
  • patient under legal protection

Trial contacts and locations

1

Loading...

Central trial contact

Laurence SALOMON, MD, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems